BSLK vs NIVF โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NIVF Captures Institutional Edge (2โ1 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to NewGenIvf Group Limited Class A ordinary shares (NIVF) driven by superior Growth & Margin, Momentum & Technical while BSLK counters with relative strength in Valuation. Fundamentally, BSLK trades at N/M Forward P/E with -1179.5% operating margin (+7300.0% YoY revenue) versus NIVF at N/M Forward P/E and -238.2% operating margin (-4.7% YoY). In options structure, BSLK sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NIVF sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)
| Period | BSLK Revenue | NIVF Revenue | BSLK Op. Margin | NIVF Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| Q4 '24 | $10M | N/A | -504.4% | N/A | BSLK |
| Q1 '25 | $0M | N/A | -3157.9% | N/A | BSLK |
| Q2 '25 | $10M | N/A | -370.0% | N/A | BSLK |
| Q3 '25 | $0M | $10M | -1179.5% | -195.9% | NIVF |
| Q4 '25 | N/A | $10M | N/A | -349.1% | NIVF |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BSLK | NIVF | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $7.1M | $369,508 | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | 0.1x | N/M | Lower Multiple | BSLK |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +7300.0% | -4.7% | Higher Growth | BSLK |
| Operating Margin (TTM) Profitability | -1179.5% | -238.2% | Higher Margin | NIVF |
| Net Profit Margin Profitability | 0.0% | 24.2% | Higher Margin | NIVF |
| Return on Equity (ROE) Capital Efficiency | -4288.3% | 5.5% | Higher ROE | NIVF |
| 52-Week Range Position Momentum | 0% ($1โ$25) | 5% ($0โ$3) | Stronger Trend | NIVF |
| Beta / 30D Volatility Risk Regime | 4.04ฮฒ ยท 148% Vol | 0.07ฮฒ ยท 3093% Vol | Lower Realized Risk | BSLK |
| Unified Institutional Score Composite Signal | 41.2 / 100 (SELL) | 42.4 / 100 (HOLD) | Higher Composite | NIVF |